secwatch / observer
8-K filed January 21, 2022, 6:59 PM ET ticker APVO CIK 0001671584
leadership confidence high sentiment neutral materiality 0.50

Aptevo Chairman Fuad El-Hibri retires; John Niederhuber named Chairman effective April 1, 2022

Aptevo Therapeutics Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Fuad El-Hibri

Chairman of the Board
APVO · Aptevo Therapeutics Inc.
Effective
2022-04-01
Successor
John Niederhuber
Filed
January 21, 2022, 6:59 PM ET
On January 21, 2022, Fuad El-Hibri, Chairman of the Board of Directors (“Board”) of Aptevo Therapeutics Inc. (“Company”), notified the Company of his retirement and resignation as a director of the Company, effective April 1, 2022.
Appointed

John Niederhuber

Chairman of the Board
APVO · Aptevo Therapeutics Inc.
Effective
2022-04-01
Filed
January 21, 2022, 6:59 PM ET
On January 21, 2022, the Board appointed John Niederhuber, M.D. as Chairman of the Board effective April 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Fuad El-Hibri departed as Chairman of the Board at Aptevo Therapeutics Inc..

Action
retired and resigned
Role
Chairman of the Board
Exact text from the filing
On January 21, 2022, Fuad El-Hibri, Chairman of the Board of Directors (“Board”) of Aptevo Therapeutics Inc. (“Company”), notified the Company of his retirement and resignation as a director of the Company, effective April 1, 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

John Niederhuber was appointed as Chairman of the Board at Aptevo Therapeutics Inc..

Action
appointed
Role
Chairman of the Board
Exact text from the filing
On January 21, 2022, the Board appointed John Niederhuber, M.D. as Chairman of the Board effective April 1, 2022.
View on SEC.gov

Aptevo Therapeutics Inc. filing history →

Source: SEC EDGAR
accession 0001564590-22-001848
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.